Nicotine self-administration in the rat: Effects of hypocretin antagonists and changes in hypocretin mRNA

Psychopharmacology

Volumn 209, Issue 2, 2010, Pages 203-212

  LeSage, Mark G ^a,b   Perry, Jennifer L ^a   Kotz, Catherine M ^c   Shelley, David ^a   Corrigall, William A ^a,d  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Almorexant; Hypocretin; Nicotine; Reinforcement; SB334867; Self administration

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ALMOREXANT; MESSENGER RNA; NICOTINE; OREXIN; OREXIN A; OREXIN B; ((2R) 2 ((1S) 6,7 DIMETHOXY 1 (2 (4 TRIFLUOROMETHYLPHENYL) ETHYL) 3,4 DIHYDRO 1H ISOQUINOLIN 2 YL) N METHYL 2 PHENYLACETAMIDE); ((2R)-2-((1S)-6,7-DIMETHOXY-1-(2-(4-TRIFLUOROMETHYLPHENYL)-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-N-METHYL-2-PHENYLACETAMIDE); 1 (2 METHYLBENZOXAZOL 6 YL) 3 (1,5)NAPHTHYRIDIN 4 YL UREA; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; ACETAMIDE DERIVATIVE; BENZOXAZOLE DERIVATIVE; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; ISOQUINOLINE DERIVATIVE; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NICOTINIC AGENT; OREXIN RECEPTORS; OREXINS; SIGNAL PEPTIDE; UREA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; HYPOCRETIN 1 GENE; HYPOCRETIN 2 GENE; HYPOCRETIN GENE; LATERAL HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; ANIMAL; ARCUATE NUCLEUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; LONG EVANS RAT; METABOLISM;

ACETAMIDES; ANIMALS; ARCUATE NUCLEUS; BEHAVIOR, ANIMAL; BENZOXAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMUS; INFUSIONS, INTRAVENOUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOQUINOLINES; MALE; NEUROPEPTIDES; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, LONG-EVANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REINFORCEMENT (PSYCHOLOGY); RNA, MESSENGER; SELF ADMINISTRATION; UREA;

EID: 77952777621     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1792-0     Document Type: Article

References (62)

1. Alderson HL, Latimer MP, Winn P (2006) Intravenous selfadministration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus. Eur J NeuroSci 23:2169-2175
2. Aston-Jones G, Smith RJ, Moorman DE, Richardson KA (2009) Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56(Suppl 1):112-121
3. Bonci A, Borgland S (2009) Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 56(Suppl 1):107-111
4. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A (2009) Orexin A/ hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29:11215-11225
5. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601 (Pubitemid 43221893)
6. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L (2005) Role for hypocretin in mediating stressinduced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 102:19168-19173 (Pubitemid 43049584)
7. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13:150-155
8. Brischoux F, Mainville L, Jones BE (2008) Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 510:607-630
9. Coen KM, Adamson KL, Corrigall WA (2009) Medication-related pharmacological manipulations of nicotine self-Administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement. Psychopharmacology (Berl) 201:557-568
10. Comer SD, Turner DM, Carroll ME (1995) Effects of food deprivation on cocaine base smoking in rhesus monkeys. Psychopharmacology (Berl) 119:127-132
11. Corrigall WA (2009) Hypocretin mechanisms in nicotine addiction: Evidence and speculation. Psychopharmacology (Berl) 206:23-37
12. Corrigall WA, Coen KM (1989) Nicotine maintains robust selfadministration in rats on a limited-Access schedule. Psychopharmacology (Berl) 99:473-478 (Pubitemid 19273101)
13. Corrigall WA, Coen KM, Adamson KL (1994) Self-Administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284 (Pubitemid 24252850)
14. de Lecea L, Jones BE, Boutrel B, Borgland SL, Nishino S, Bubser M, DiLeone R (2006) Addiction and arousal: Alternative roles of hypothalamic peptides. J Neurosci 26:10372-10375 (Pubitemid 44564586)
15. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327 (Pubitemid 28103952)
16. de Lecea L, Sutcliffe JG, Fabre V (2002) Hypocretins/orexins as integrators of physiological information: Lessons from mutant animals. Neuropeptides 36:85-95
17. Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW (2009) Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 330:142-151
18. Duxon MS, Stretton J, Starr K, Jones DN, Holland V, Riley G, Jerman J, Brough S, Smart D, Johns A, Chan W, Porter RA, Upton N (2001) Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement. Psychopharmacology (Berl) 153:203-209 (Pubitemid 32127888)
19. España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR (2010) The hypocretin-orexin system regulates cocaine selfadministration via actions on the mesolimbic dopamine system. Eur J NeuroSci 31:336-348
20. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111 (Pubitemid 36531950)
21. Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227 (Pubitemid 46654234)
22. Greco MA, Shiromani PJ (2001) Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol Brain Res 88:176-182 (Pubitemid 32274273)
23. Harris GC, Aston-Jones G (2006) Arousal and reward: A dichotomy in orexin function. Trends Neurosci 29:571-577 (Pubitemid 44416459)
24. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559 (Pubitemid 41613553)
25. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, Arch JRS (2000) A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 96:45-51
26. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ (2008) Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci USA 105:19480-19485
27. Horvath TL, Gao X-B (2005) Input organization and plasticity of hypocretin neurons: Possible clues to obesity's association with insomnia. Cell Metab 1:279-286 (Pubitemid 43960609)
28. Kane JK, Parker SL, Matta SG, Fu Y, Sharp BM, Li MD (2000) Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 141:3623-3629
29. Kilduff TS, Peyron C (2000) The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders. Trends Neurosci 23:359-365 (Pubitemid 30628812)
30. Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K (2009) Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: An in vitro study. Peptides 30:191-209
31. Koob GF (2006) The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction 101(Suppl 1):23-30 (Pubitemid 44199493)
32. Koob GF (2008) A role for brain stress systems in addiction. Neuron 59:11-34 (Pubitemid 351905857)
33. Kotz CM (2006) Integration of feeding and spontaneous physical activity: Role for orexin. Physiol Behav 88:294-301
34. Kotz CM, Levine AS, Billington CJ (1997) Effect of naltrexone on feeding, neuropeptide Y and uncoupling protein gene expression during lactation. Neuroendocrinology 65:259-264 (Pubitemid 27152082)
35. Lambe EK, Olausson P, Horst NK, Taylor JR, Aghajanian GK (2005) Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: Correlation with improved attention in rat. J Neurosci 25:5225-5229 (Pubitemid 40726974)
36. Lança AJ, Adamson KL, CoenKM, Chow BL, CorrigallWA (2000) The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-Administration in the rat: A correlative neuroanatomical and behavioral study. Neuroscience 96:735-742 (Pubitemid 30155737)
37. Laviolette SR, Alexson TO, van der Kooy D (2002) Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J Neurosci 22:8653-8660 (Pubitemid 35387605)
38. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006) The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148:752-759 (Pubitemid 44079404)
39. LeSage MG, Burroughs D, Dufek M, Keyler DE, Pentel PR (2004) Reinstatement of nicotine self-Administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav 79:507-513 (Pubitemid 39576168)
40. Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL (2009) Biochemical and behavioural characterization of EMPA, a novel high-Affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 156:1326-1341
41. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6-25 (Pubitemid 32448719)
42. Nair SG, Golden SA, Shaham Y (2008) Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-Administration and reinstatement of food seeking in rats. Br J Pharmacol 154:406-416 (Pubitemid 351670600)
43. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K (1999) Distribution of orexin neurons in the adult rat brain. Brain Res 827:243-260 (Pubitemid 29222929)
44. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26:398-405 (Pubitemid 43237102)
45. Pan WX, Hyland BI (2005) Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats. J Neurosci 25:4725-4732 (Pubitemid 40664121)
46. Paneda C, Winsky-Sommerer R, Boutrel B, de Lecea L (2005) The corticotropin-releasing factor-hypocretin connection: Implications in stress response and addiction. Drug News Perspect 18:250-255 (Pubitemid 41094928)
47. Pasumarthi RK, Fadel J (2008) Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine. Brain Res Bull 77:367-373
48. Pasumarthi RK, Reznikov LR, Fadel J (2006) Activation of orexin neurons by acute nicotine. Eur J Pharmacol 535:172-176
49. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, New York
50. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015 (Pubitemid 28543775)
51. Porter RA, Chan WN, Coulton S, Johns A, Hadley MS, Widdowson K, Jerman JC, Brough SJ, Coldwell M, Smart D, Jewitt F, Jeffrey P, Austin N (2001) 1, 3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorg Med Chem Lett 11:1907-1910 (Pubitemid 32675315)
52. Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199:109-117
53. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Upton N, Porter RA, Johns A, Blundell JE (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J NeuroSci 13:1444-1452 (Pubitemid 32328500)
54. Rodgers RJ, Ishii Y, Halford JC, Blundell JE (2002) Orexins and appetite regulation. Neuropeptides 36:303-325 (Pubitemid 35440830)
55. Ross JT, Corrigall WA, Heidbreder CA, LeSage MG (2007) Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressiveratio schedule in rats. Eur J Pharmacol 559:173-179 (Pubitemid 46295412)
56. Sakurai T (2007) The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness. Nat Rev Neurosci 8:171-181 (Pubitemid 46294664)
57. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585 (Pubitemid 28101119)
58. Siegel JM (2004) Hypocretin (orexin): Role in normal behavior and neuropathology. Annu Rev Psychol 55:125-148
59. Smith RJ, See RE, Aston-Jones G (2009) Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J NeuroSci 30:493-503
60. Sutcliffe JG, de Lecea L (2002) The hypocretins: Setting the arousal threshold. Nat Rev Neurosci 3:339-349 (Pubitemid 135706631)
61. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438:71-75 (Pubitemid 28517837)
62. Winsky-Sommerer R, Boutrel B, de Lecea L (2005) Stress and arousal: The corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 32:285-294 (Pubitemid 43024033)